Login to Your Account



An Easy Pill to Swallow

Tris Hopes Partner Acquisition Illuminates Alternative Dosing

By Brian Orelli
BioWorld Insight Contributing Writer

Monday, October 29, 2012

Last week, Pfizer Inc. exercised the option it established earlier this year to acquire NextWave Pharmaceuticals for $255 million up front and potentially another $425 million based on certain sales milestones.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription